adjuvantadvancedalgorithmaskedbenefitbestbiologybladdercancercarcinomacarecasecellcisplatinclinicalcurrentdecisiondiseasedrivenevolvingexchangeexpertfaqsfirstfrequentlyg12chighlightsimmunotherapyineligibleinsightsinterviewinvasivekraslandscapelinelocallymaintenancemakingmanagementmaximizingmetastaticmibcmolecularmusclemutationsnmibcnsclconcogeneoptimaloptimizationosimertinibpathologypatientspracticequestionsradiotherapyreconsideringrenalresistancerolesalvagescchnsclcsecondsequentialsessionspecialiststandardstrategiesstrategysurvivaltargetingtherapeutictherapytreatmenttreatmentsucunresectableupdatesurothelialvienna